OABI FY 2022 Earnings — OmniAb, Inc. Revenue & Financial Results | Market Cap Arena

OABIOmniAb, Inc.

$231M

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$59M+70.0% YoY

Gross Profit

$59M100.0% margin

Operating Income

-$27M-45.1% margin

Net Income

-$22M-37.8% margin

EPS (Diluted)

$-0.26

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$21M

Stock-Based Comp.

$18M

Balance Sheet

Total Assets

$421M

Total Liabilities

$80M

Stockholders' Equity

$341M

Cash & Equivalents

$33M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$59M	$35M	+70.0%
Gross Profit	$59M	$35M	+70.0%
Operating Income	-$27M	-$36M	+25.2%
Net Income	-$22M	-$27M	+17.4%